AMYLIN PHARMACEUTICALS INC Other Restructuring Costs
AMYLIN PHARMACEUTICALS INC reported Other Restructuring Costs of $2.50 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-10-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2011-10-28
- AMYLIN PHARMACEUTICALS INC other restructuring costs for the quarter ending 2011-09-30 was $2.50M, a 58.54% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for the quarter ending 2011-06-30 was $126.00K, a 96.32% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for the quarter ending 2011-03-31 was $2.86M.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for the quarter ending 2010-12-31 was $7.33M, a 30.76% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for fiscal 2010 was $16.78M, a 1.18% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for fiscal 2009 was $16.98M, a 69.09% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC other restructuring costs for fiscal 2008 was $54.93M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2011-09-30 | $2.50M 10-Q · filed 2011-10-28 | $2.63M derived: sum of 2 quarters · filed 2011-10-28 | $5.48M 10-Q · filed 2011-10-28 | $12.81M derived: sum of 4 quarters · filed 2011-10-28 |
| 2011-06-30 | $126.00K 10-Q · filed 2011-08-08 | $2.98M 10-Q · filed 2011-08-08 | $10.31M derived: sum of 3 quarters · filed 2011-08-08 | $16.34M derived: sum of 4 quarters · filed 2011-10-28 |
| 2011-03-31 | $2.86M 10-Q · filed 2011-05-05 | $10.19M derived: sum of 2 quarters · filed 2011-05-05 | $16.21M derived: sum of 3 quarters · filed 2011-10-28 | $19.64M derived: sum of 4 quarters · filed 2011-10-28 |
| 2010-12-31 | $7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $13.36M derived: sum of 2 quarters · filed 2011-10-28 | $16.78M derived: sum of 3 quarters · filed 2011-10-28 | $16.78M 10-K · filed 2011-02-25 |
| 2010-09-30 | $6.03M 10-Q · filed 2011-10-28 | $9.45M derived: sum of 2 quarters · filed 2011-10-28 | $9.45M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $3.42M 10-Q · filed 2011-08-08 | $3.42M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $5.60M derived: sum of 2 quarters · filed 2011-02-25 | $16.98M derived: sum of 3 quarters · filed 2011-02-25 | $16.98M 10-K · filed 2011-02-25 |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $11.38M derived: sum of 2 quarters · filed 2010-11-08 | $11.38M 10-Q · filed 2010-11-08 | |
| 2009-06-30 | $11.38M 10-Q · filed 2010-08-05 | $11.38M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | $54.93M 10-K · filed 2011-02-25 |